2023-2029 Global Targeted Drugs for Colorectal Cancer Industry Research & Trends Analysis Report
2023-2029 Global Targeted Drugs for Colorectal Cancer Industry Research & Trends Analysis Report
The Targeted Drugs for Colorectal Cancer study provides a comprehensive overview of safety standards, market penetration, and innovation pipelines across major economies.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to Latest Study, the global market for Targeted Drugs for Colorectal Cancer should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Targeted Drugs for Colorectal Cancer market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Targeted Drugs for Colorectal Cancer market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, EGFR Target segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Targeted Drugs for Colorectal Cancer include Merck, Amgen, F. Hoffmann-La Roche Ltd, Novartis, Array BioPharma, Genentech, Bayer, Sanofi and Lilly, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
Targeted therapy is to design corresponding therapeutic drugs for the identified cancer-causing site (the site can be a protein molecule inside the tumor cell or a gene fragment) at the cellular molecular level, and the drug enters the body It will specifically select oncogenic sites to combine and act, so that tumor cells will die specifically, without affecting normal tissue cells around the tumor.
This report aims to provide a comprehensive study of the global market for Targeted Drugs for Colorectal Cancer. Report Highlights:
(1) Global Targeted Drugs for Colorectal Cancer market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Targeted Drugs for Colorectal Cancer market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(3) China Targeted Drugs for Colorectal Cancer market competitive situation, sales, revenue, price and market share, from 2018 to 2022.
(4) Global Targeted Drugs for Colorectal Cancer segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Targeted Drugs for Colorectal Cancer segment by type and by application and regional segment by type and by application.
(6) Global major production regions of Targeted Drugs for Colorectal Cancer, capacity, production and trends.
(7) Targeted Drugs for Colorectal Cancer industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
EGFR Target
BRAF Target
MEK1/2 Targets
BRAF V600 Target
HER2 Target
VEGFR-1/2/3 Targets
PD-1 Target
CTLA-4 Target
Market segment by application, can be divided into
Hospital
Specialty Clinic
Market segment by players, this report covers
Merck
Amgen
F. Hoffmann-La Roche Ltd
Novartis
Array BioPharma
Genentech
Bayer
Sanofi
Lilly
Bristol myers squibb
MSD lreland
HUTCHMED
1 Market Overview
1.1 Targeted Drugs for Colorectal Cancer Definition
1.2 Global Targeted Drugs for Colorectal Cancer Market Size and Forecast
1.2.1 By Revenue, Global Targeted Drugs for Colorectal Cancer Market Size, 2018-2029
1.2.2 By Sales Volume, Global Targeted Drugs for Colorectal Cancer Market Size, 2018-2029
1.2.3 Global Targeted Drugs for Colorectal Cancer Price Trend, 2018-2029
1.3 China Targeted Drugs for Colorectal Cancer Market Size and Forecast
1.3.1 By Revenue, China Targeted Drugs for Colorectal Cancer Market Size, 2018-2029
1.3.2 By Sales Volume, China Targeted Drugs for Colorectal Cancer Market Size, 2018-2029
1.3.3 China Targeted Drugs for Colorectal Cancer Price Trend, 2018-2029
1.4 China Percentage in Global Market
1.4.1 By Revenue, China Targeted Drugs for Colorectal Cancer Share in Global Market, 2018-2029
1.4.2 By Sales Volume, China Targeted Drugs for Colorectal Cancer Share in Global Market, 2018-2029
1.4.3 Targeted Drugs for Colorectal Cancer Market Size: China VS Global, 2018-2029
1.5 Targeted Drugs for Colorectal Cancer Market Dynamics
1.5.1 Targeted Drugs for Colorectal Cancer Market Drivers
1.5.2 Targeted Drugs for Colorectal Cancer Market Restraints
1.5.3 Targeted Drugs for Colorectal Cancer Industry Trends
1.5.4 Targeted Drugs for Colorectal Cancer Industry Policy
2 Global Competitive Landscape by Company
2.1 Global Targeted Drugs for Colorectal Cancer Revenue by Company, 2018-2023
2.2 Global Targeted Drugs for Colorectal Cancer Sales Volume by Company, 2018-2023
2.3 Global Targeted Drugs for Colorectal Cancer Price by Company, 2018-2023
2.4 Global Targeted Drugs for Colorectal Cancer Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.5 Global Targeted Drugs for Colorectal Cancer Concentration Ratio
2.6 Global Targeted Drugs for Colorectal Cancer Mergers & Acquisitions, Expansion Plans
2.7 Global Targeted Drugs for Colorectal Cancer Manufacturers Product Type
3 China Competitive Landscape by Company
3.1 China Targeted Drugs for Colorectal Cancer Revenue by Company, 2018-2023
3.2 China Targeted Drugs for Colorectal Cancer Sales Volume by Company, 2018-2023
3.3 China Targeted Drugs for Colorectal Cancer Targeted Drugs for Colorectal Cancer Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.4 China Targeted Drugs for Colorectal Cancer Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)
3.5 Chinese Local Players, Targeted Drugs for Colorectal Cancer Domestic VS Export
3.6 China Market, Targeted Drugs for Colorectal Cancer Import & Export
3.6.1 China Market, Targeted Drugs for Colorectal Cancer Import & Export, 2018-2029
3.6.2 China Targeted Drugs for Colorectal Cancer Import & Export Trends
3.6.3 Main Sources of China Targeted Drugs for Colorectal Cancer Import
3.6.4 Export Destination of China Targeted Drugs for Colorectal Cancer
4 Targeted Drugs for Colorectal Cancer Production by Region
4.1 Global Targeted Drugs for Colorectal Cancer Capacity, Production and Capacity Utilization, 2018-2029
4.2 Global Geographic Distribution of Targeted Drugs for Colorectal Cancer Manufacturers
4.3 Global Major Manufacturers, Targeted Drugs for Colorectal Cancer Capacity Expansion and Future Plans
4.4 Global Targeted Drugs for Colorectal Cancer Capacity by Region
4.5 Global Targeted Drugs for Colorectal Cancer Production by Region
4.5.1 Global Targeted Drugs for Colorectal Cancer Production & Forecast by Region, 2018 VS 2022 VS 2029
4.5.2 Global Targeted Drugs for Colorectal Cancer Production by Region, 2018-2023
4.5.3 Global Targeted Drugs for Colorectal Cancer Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Targeted Drugs for Colorectal Cancer Industry Chain
5.2 Targeted Drugs for Colorectal Cancer Upstream Analysis
5.2.1 Targeted Drugs for Colorectal Cancer Core Raw Materials
5.2.2 Main Manufacturers of Targeted Drugs for Colorectal Cancer Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Targeted Drugs for Colorectal Cancer Production Mode
5.6 Targeted Drugs for Colorectal Cancer Procurement Model
5.7 Targeted Drugs for Colorectal Cancer Industry Sales Model and Sales Channels
5.7.1 Targeted Drugs for Colorectal Cancer Sales Model
5.7.2 Targeted Drugs for Colorectal Cancer Typical Distributors
6 Sights by Type
6.1 Targeted Drugs for Colorectal Cancer Classification
6.1.1 EGFR Target
6.1.2 BRAF Target
6.1.3 MEK1/2 Targets
6.1.4 BRAF V600 Target
6.1.5 HER2 Target
6.1.6 VEGFR-1/2/3 Targets
6.1.7 PD-1 Target
6.1.8 CTLA-4 Target
6.2 By Type, Global Targeted Drugs for Colorectal Cancer Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Targeted Drugs for Colorectal Cancer Revenue, 2018-2029
6.4 By Type, Global Targeted Drugs for Colorectal Cancer Sales Volume, 2018-2029
6.5 By Type, Global Targeted Drugs for Colorectal Cancer Price, 2018-2029
7 Sights by Application
7.1 Targeted Drugs for Colorectal Cancer Segment by Application
7.1.1 Hospital
7.1.2 Specialty Clinic
7.2 By Application, Global Targeted Drugs for Colorectal Cancer Market Size & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Targeted Drugs for Colorectal Cancer Revenue, 2018-2029
7.4 By Application, Global Targeted Drugs for Colorectal Cancer Sales Volume, 2018-2029
7.5 By Application, Global Targeted Drugs for Colorectal Cancer Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Targeted Drugs for Colorectal Cancer Market Size, 2018 VS 2022 VS 2029
8.2 By Region, Global Targeted Drugs for Colorectal Cancer Revenue, 2018-2029
8.3 By Region, Global Targeted Drugs for Colorectal Cancer Sales Volume, 2018-2029
8.4 North America
8.4.1 North America Targeted Drugs for Colorectal Cancer Market Size & Forecasts, 2018-2029
8.4.2 By Country, North America Targeted Drugs for Colorectal Cancer Market Size Market Share
8.5 Europe
8.5.1 Europe Targeted Drugs for Colorectal Cancer Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Targeted Drugs for Colorectal Cancer Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Targeted Drugs for Colorectal Cancer Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Targeted Drugs for Colorectal Cancer Market Size Market Share
8.7 South America
8.7.1 South America Targeted Drugs for Colorectal Cancer Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Targeted Drugs for Colorectal Cancer Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Targeted Drugs for Colorectal Cancer Market Size & CAGR，2018 VS 2022 VS 2029
9.2 By Country, Global Targeted Drugs for Colorectal Cancer Revenue, 2018-2029
9.3 By Country, Global Targeted Drugs for Colorectal Cancer Sales Volume, 2018-2029
9.4 U.S.
9.4.1 U.S. Targeted Drugs for Colorectal Cancer Market Size, 2018-2029
9.4.2 By Company, U.S. Targeted Drugs for Colorectal Cancer Sales Volume Market Share, 2022
9.4.3 By Type, U.S. Targeted Drugs for Colorectal Cancer Market Size, Share, 2022 VS 2029
9.4.4 By Application, U.S. Targeted Drugs for Colorectal Cancer Market Size, Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Targeted Drugs for Colorectal Cancer Market Size, 2018-2029
9.5.2 By Company, Europe Targeted Drugs for Colorectal Cancer Sales Volume Market Share, 2022
9.5.3 By Type, Europe Targeted Drugs for Colorectal Cancer Market Size, Share, 2022 VS 2029
9.5.4 By Application, Europe Targeted Drugs for Colorectal Cancer Market Size, Share, 2022 VS 2029
9.6 China
9.6.1 China Targeted Drugs for Colorectal Cancer Market Size, 2018-2029
9.6.2 By Company, China Targeted Drugs for Colorectal Cancer Sales Volume Market Share, 2022
9.6.3 By Type, China Targeted Drugs for Colorectal Cancer Market Size, Share, 2022 VS 2029
9.6.4 By Application, China Targeted Drugs for Colorectal Cancer Market Size, Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Targeted Drugs for Colorectal Cancer Market Size, 2018-2029
9.7.2 By Company, Japan Targeted Drugs for Colorectal Cancer Sales Volume Market Share, 2022
9.7.3 By Type, Japan Targeted Drugs for Colorectal Cancer Market Size, Share, 2022 VS 2029
9.7.4 By Application, Japan Targeted Drugs for Colorectal Cancer Market Size, Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Targeted Drugs for Colorectal Cancer Market Size, 2018-2029
9.8.2 By Company, South Korea Targeted Drugs for Colorectal Cancer Sales Volume Market Share, 2022
9.8.3 By Type, South Korea Targeted Drugs for Colorectal Cancer Market Size, Share, 2022 VS 2029
9.8.4 By Application, South Korea Targeted Drugs for Colorectal Cancer Market Size, Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Targeted Drugs for Colorectal Cancer Market Size, 2018-2029
9.9.2 By Company, Southeast Asia Targeted Drugs for Colorectal Cancer Sales Volume Market Share, 2022
9.9.3 By Type, Southeast Asia Targeted Drugs for Colorectal Cancer Market Size, Share, 2022 VS 2029
9.9.4 By Application, Southeast Asia Targeted Drugs for Colorectal Cancer Market Size, Share, 2022 VS 2029
9.10 India
9.10.1 India Targeted Drugs for Colorectal Cancer Market Size, 2018-2029
9.10.2 By Company, India Targeted Drugs for Colorectal Cancer Sales Volume Market Share, 2022
9.10.3 By Type, India Targeted Drugs for Colorectal Cancer Market Size, Share, 2022 VS 2029
9.10.4 By Application, India Targeted Drugs for Colorectal Cancer Market Size, Share, 2022 VS 2029
9.11 Middle East & Asia
9.11.1 Middle East & Asia Targeted Drugs for Colorectal Cancer Market Size, 2018-2029
9.11.2 By Company, Middle East & Asia Targeted Drugs for Colorectal Cancer Sales Volume Market Share, 2022
9.11.3 By Type, Middle East & Asia Targeted Drugs for Colorectal Cancer Market Size, Share, 2022 VS 2029
9.11.4 By Application, Middle East & Asia Targeted Drugs for Colorectal Cancer Market Size, Share, 2022 VS 2029
10 Manufacturers Profile
10.1 Merck
10.1.1 Merck Company Information, Head Office, Market Area and Industry Position
10.1.2 Merck Targeted Drugs for Colorectal Cancer Models, Specifications and Application
10.1.3 Merck Targeted Drugs for Colorectal Cancer Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.1.4 Merck Company Profile and Main Business
10.1.5 Merck Recent Developments
10.2 Amgen
10.2.1 Amgen Company Information, Head Office, Market Area and Industry Position
10.2.2 Amgen Targeted Drugs for Colorectal Cancer Models, Specifications and Application
10.2.3 Amgen Targeted Drugs for Colorectal Cancer Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Amgen Company Profile and Main Business
10.2.5 Amgen Recent Developments
10.3 F. Hoffmann-La Roche Ltd
10.3.1 F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area and Industry Position
10.3.2 F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Models, Specifications and Application
10.3.3 F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.3.4 F. Hoffmann-La Roche Ltd Company Profile and Main Business
10.3.5 F. Hoffmann-La Roche Ltd Recent Developments
10.4 Novartis
10.4.1 Novartis Company Information, Head Office, Market Area and Industry Position
10.4.2 Novartis Targeted Drugs for Colorectal Cancer Models, Specifications and Application
10.4.3 Novartis Targeted Drugs for Colorectal Cancer Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Novartis Company Profile and Main Business
10.4.5 Novartis Recent Developments
10.5 Array BioPharma
10.5.1 Array BioPharma Company Information, Head Office, Market Area and Industry Position
10.5.2 Array BioPharma Targeted Drugs for Colorectal Cancer Models, Specifications and Application
10.5.3 Array BioPharma Targeted Drugs for Colorectal Cancer Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Array BioPharma Company Profile and Main Business
10.5.5 Array BioPharma Recent Developments
10.6 Genentech
10.6.1 Genentech Company Information, Head Office, Market Area and Industry Position
10.6.2 Genentech Targeted Drugs for Colorectal Cancer Models, Specifications and Application
10.6.3 Genentech Targeted Drugs for Colorectal Cancer Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.6.4 Genentech Company Profile and Main Business
10.6.5 Genentech Recent Developments
10.7 Bayer
10.7.1 Bayer Company Information, Head Office, Market Area and Industry Position
10.7.2 Bayer Targeted Drugs for Colorectal Cancer Models, Specifications and Application
10.7.3 Bayer Targeted Drugs for Colorectal Cancer Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Bayer Company Profile and Main Business
10.7.5 Bayer Recent Developments
10.8 Sanofi
10.8.1 Sanofi Company Information, Head Office, Market Area and Industry Position
10.8.2 Sanofi Targeted Drugs for Colorectal Cancer Models, Specifications and Application
10.8.3 Sanofi Targeted Drugs for Colorectal Cancer Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Sanofi Company Profile and Main Business
10.8.5 Sanofi Recent Developments
10.9 Lilly
10.9.1 Lilly Company Information, Head Office, Market Area and Industry Position
10.9.2 Lilly Targeted Drugs for Colorectal Cancer Models, Specifications and Application
10.9.3 Lilly Targeted Drugs for Colorectal Cancer Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.9.4 Lilly Company Profile and Main Business
10.9.5 Lilly Recent Developments
10.10 Bristol myers squibb
10.10.1 Bristol myers squibb Company Information, Head Office, Market Area and Industry Position
10.10.2 Bristol myers squibb Targeted Drugs for Colorectal Cancer Models, Specifications and Application
10.10.3 Bristol myers squibb Targeted Drugs for Colorectal Cancer Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Bristol myers squibb Company Profile and Main Business
10.10.5 Bristol myers squibb Recent Developments
10.11 MSD lreland
10.11.1 MSD lreland Company Information, Head Office, Market Area and Industry Position
10.11.2 MSD lreland Targeted Drugs for Colorectal Cancer Models, Specifications and Application
10.11.3 MSD lreland Targeted Drugs for Colorectal Cancer Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.11.4 MSD lreland Company Profile and Main Business
10.11.5 MSD lreland Recent Developments
10.12 HUTCHMED
10.12.1 HUTCHMED Company Information, Head Office, Market Area and Industry Position
10.12.2 HUTCHMED Targeted Drugs for Colorectal Cancer Models, Specifications and Application
10.12.3 HUTCHMED Targeted Drugs for Colorectal Cancer Sales Volume, Revenue, Price and Gross Margin, 2018-2023
10.12.4 HUTCHMED Company Profile and Main Business
10.12.5 HUTCHMED Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Targeted Drugs for Colorectal Cancer Market Size & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Targeted Drugs for Colorectal Cancer Market Restraints
Table 3. Targeted Drugs for Colorectal Cancer Market Trends
Table 4. Targeted Drugs for Colorectal Cancer Industry Policy
Table 5. Global Targeted Drugs for Colorectal Cancer Revenue by Company, 2018-2023, US$ million
Table 6. Global Targeted Drugs for Colorectal Cancer Revenue Market Share by Company, 2018-2023
Table 7. Global Targeted Drugs for Colorectal Cancer Sales Volume by Company, 2018-2023, (K Units)
Table 8. Global Targeted Drugs for Colorectal Cancer Sales Volume Market Share by Company, 2018-2023
Table 9. Global Targeted Drugs for Colorectal Cancer Price by Company, 2018-2023, (US$/Unit)
Table 10. Global Targeted Drugs for Colorectal Cancer Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Targeted Drugs for Colorectal Cancer Mergers & Acquisitions, Expansion Plans
Table 12. Global Targeted Drugs for Colorectal Cancer Manufacturers Product Type
Table 13. China Targeted Drugs for Colorectal Cancer Revenue by Company, 2018-2023, US$ million
Table 14. China Targeted Drugs for Colorectal Cancer Revenue Market Share by Company, 2018-2023
Table 15. China Targeted Drugs for Colorectal Cancer Sales Volume by Company, 2018-2023, (K Units)
Table 16. China Targeted Drugs for Colorectal Cancer Sales Volume Market Share by Company, 2018-2023
Table 17. China Market, Targeted Drugs for Colorectal Cancer Production, Sales, Import and Export, 2018-2029, (K Units)
Table 18. China Targeted Drugs for Colorectal Cancer Import & Export Trends
Table 19. Main Sources of China Targeted Drugs for Colorectal Cancer Import
Table 20. Export Destination of China Targeted Drugs for Colorectal Cancer
Table 21. Global Headquarters and Manufacturing Base of Targeted Drugs for Colorectal Cancer Manufacturers
Table 22. Global Major Manufacturers, Targeted Drugs for Colorectal Cancer Capacity Expansion and Future Plans
Table 23. Global Targeted Drugs for Colorectal Cancer Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 24. Global Targeted Drugs for Colorectal Cancer Production by Region, 2018-2023, (K Units)
Table 25. Global Targeted Drugs for Colorectal Cancer Production Forecast by Region, 2023-2029, (K Units)
Table 26. Global Key Players of Targeted Drugs for Colorectal Cancer Upstream (Raw Materials)
Table 27. Global Targeted Drugs for Colorectal Cancer Typical Customers
Table 28. Targeted Drugs for Colorectal Cancer Typical Distributors
Table 29. By Type, Global Targeted Drugs for Colorectal Cancer Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Application, Global Targeted Drugs for Colorectal Cancer Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 31. By Region, Global Targeted Drugs for Colorectal Cancer Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 32. By Region, Global Targeted Drugs for Colorectal Cancer Revenue, 2018-2029, US$ Million
Table 33. By Region, Global Targeted Drugs for Colorectal Cancer Sales Volume, 2018-2029, (K Units)
Table 34. By Country, Global Targeted Drugs for Colorectal Cancer Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million
Table 35. By Country, Global Targeted Drugs for Colorectal Cancer Revenue, 2018-2029, US$ Million
Table 36. By Country, Global Targeted Drugs for Colorectal Cancer Revenue Market Share, 2018-2029
Table 37. By Country, Global Targeted Drugs for Colorectal Cancer Sales Volume, 2018-2029, (K Units)
Table 38. By Country, Global Targeted Drugs for Colorectal Cancer Sales Volume Market Share, 2018-2029
Table 39. Merck Company Information, Head Office, Market Area and Industry Position
Table 40. Merck Targeted Drugs for Colorectal Cancer Models, Specifications and Application
Table 41. Merck Targeted Drugs for Colorectal Cancer Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Merck Company Profile and Main Business
Table 43. Merck Recent Developments
Table 44. Amgen Company Information, Head Office, Market Area and Industry Position
Table 45. Amgen Targeted Drugs for Colorectal Cancer Models, Specifications and Application
Table 46. Amgen Targeted Drugs for Colorectal Cancer Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Amgen Company Profile and Main Business
Table 48. Amgen Recent Developments
Table 49. F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area and Industry Position
Table 50. F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Models, Specifications and Application
Table 51. F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. F. Hoffmann-La Roche Ltd Company Profile and Main Business
Table 53. F. Hoffmann-La Roche Ltd Recent Developments
Table 54. Novartis Company Information, Head Office, Market Area and Industry Position
Table 55. Novartis Targeted Drugs for Colorectal Cancer Models, Specifications and Application
Table 56. Novartis Targeted Drugs for Colorectal Cancer Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Novartis Company Profile and Main Business
Table 58. Novartis Recent Developments
Table 59. Array BioPharma Company Information, Head Office, Market Area and Industry Position
Table 60. Array BioPharma Targeted Drugs for Colorectal Cancer Models, Specifications and Application
Table 61. Array BioPharma Targeted Drugs for Colorectal Cancer Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. Array BioPharma Company Profile and Main Business
Table 63. Array BioPharma Recent Developments
Table 64. Genentech Company Information, Head Office, Market Area and Industry Position
Table 65. Genentech Targeted Drugs for Colorectal Cancer Models, Specifications and Application
Table 66. Genentech Targeted Drugs for Colorectal Cancer Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Genentech Company Profile and Main Business
Table 68. Genentech Recent Developments
Table 69. Bayer Company Information, Head Office, Market Area and Industry Position
Table 70. Bayer Targeted Drugs for Colorectal Cancer Models, Specifications and Application
Table 71. Bayer Targeted Drugs for Colorectal Cancer Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Bayer Company Profile and Main Business
Table 73. Bayer Recent Developments
Table 74. Sanofi Company Information, Head Office, Market Area and Industry Position
Table 75. Sanofi Targeted Drugs for Colorectal Cancer Models, Specifications and Application
Table 76. Sanofi Targeted Drugs for Colorectal Cancer Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. Sanofi Company Profile and Main Business
Table 78. Sanofi Recent Developments
Table 79. Lilly Company Information, Head Office, Market Area and Industry Position
Table 80. Lilly Targeted Drugs for Colorectal Cancer Models, Specifications and Application
Table 81. Lilly Targeted Drugs for Colorectal Cancer Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Lilly Company Profile and Main Business
Table 83. Lilly Recent Developments
Table 84. Bristol myers squibb Company Information, Head Office, Market Area and Industry Position
Table 85. Bristol myers squibb Targeted Drugs for Colorectal Cancer Models, Specifications and Application
Table 86. Bristol myers squibb Targeted Drugs for Colorectal Cancer Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Bristol myers squibb Company Profile and Main Business
Table 88. Bristol myers squibb Recent Developments
Table 89. MSD lreland Company Information, Head Office, Market Area and Industry Position
Table 90. MSD lreland Targeted Drugs for Colorectal Cancer Models, Specifications and Application
Table 91. MSD lreland Targeted Drugs for Colorectal Cancer Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. MSD lreland Company Profile and Main Business
Table 93. MSD lreland Recent Developments
Table 94. HUTCHMED Company Information, Head Office, Market Area and Industry Position
Table 95. HUTCHMED Targeted Drugs for Colorectal Cancer Models, Specifications and Application
Table 96. HUTCHMED Targeted Drugs for Colorectal Cancer Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. HUTCHMED Company Profile and Main Business
Table 98. HUTCHMED Recent Developments
List of Figure
Figure 1. Targeted Drugs for Colorectal Cancer Picture
Figure 2. By Revenue, Global Targeted Drugs for Colorectal Cancer Market Size and Forecast, 2018-2029, US$ Million
Figure 3. By Sales Volume, Global Targeted Drugs for Colorectal Cancer Market Size and Forecast, 2018-2029, (K Units)
Figure 4. Global Targeted Drugs for Colorectal Cancer Price Trend, 2018-2029, (US$/Unit)
Figure 5. By Revenue, China Targeted Drugs for Colorectal Cancer Market Size and Forecast, 2018-2029, US$ million
Figure 6. By Sales Volume, China Targeted Drugs for Colorectal Cancer Market Size and Forecast, 2018-2029, (K Units)
Figure 7. China Targeted Drugs for Colorectal Cancer Price Trend, 2018-2029 (US$/Unit)
Figure 8. By Revenue, China Targeted Drugs for Colorectal Cancer Share of Global Market, 2018-2029
Figure 9. By Sales Volume, China Targeted Drugs for Colorectal Cancer Share of Global Market, 2018-2029
Figure 10. Global Targeted Drugs for Colorectal Cancer Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 11. Global Targeted Drugs for Colorectal Cancer Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022
Figure 12. China Targeted Drugs for Colorectal Cancer Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 13. China Targeted Drugs for Colorectal Cancer Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 14. China Targeted Drugs for Colorectal Cancer Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 15. Chinese Local Players, Proportion of Targeted Drugs for Colorectal Cancer Domestic VS Export, 2022
Figure 16. Global Targeted Drugs for Colorectal Cancer Capacity, Production and Capacity Utilization, 2018-2029
Figure 17. Global Targeted Drugs for Colorectal Cancer Capacity Market Share by Region, 2022 VS 2029
Figure 18. Global Targeted Drugs for Colorectal Cancer Production Market Share & Forecast by Region, 2018-2029
Figure 19. Targeted Drugs for Colorectal Cancer Industry Chain
Figure 20. Targeted Drugs for Colorectal Cancer Procurement Model
Figure 21. Targeted Drugs for Colorectal Cancer Sales Model
Figure 22. Targeted Drugs for Colorectal Cancer Sales Channels, Direct Sales and Distribution
Figure 23. EGFR Target
Figure 24. BRAF Target
Figure 25. MEK1/2 Targets
Figure 26. BRAF V600 Target
Figure 27. HER2 Target
Figure 28. VEGFR-1/2/3 Targets
Figure 29. PD-1 Target
Figure 30. CTLA-4 Target
Figure 31. By Type, Global Targeted Drugs for Colorectal Cancer Revenue, 2018-2029, US$ Million
Figure 32. By Type, Global Targeted Drugs for Colorectal Cancer Revenue Market Share, 2018-2029
Figure 33. By Type, Global Targeted Drugs for Colorectal Cancer Sales Volume, 2018-2029, (K Units)
Figure 34. By Type, Global Targeted Drugs for Colorectal Cancer Sales Volume Market Share, 2018-2029
Figure 35. By Type, Global Targeted Drugs for Colorectal Cancer Price, 2018-2029, (US$/Unit)
Figure 36. Hospital
Figure 37. Specialty Clinic
Figure 38. By Application, Global Targeted Drugs for Colorectal Cancer Revenue, 2018-2029, US$ Million
Figure 39. By Application, Global Targeted Drugs for Colorectal Cancer Revenue Market Share, 2018-2029
Figure 40. By Application, Global Targeted Drugs for Colorectal Cancer Sales Volume, 2018-2029, (K Units)
Figure 41. By Application, Global Targeted Drugs for Colorectal Cancer Sales Volume Market Share, 2018-2029
Figure 42. By Application, Global Targeted Drugs for Colorectal Cancer Price, 2018-2029, (US$/Unit)
Figure 43. By Region, Global Targeted Drugs for Colorectal Cancer Revenue Market Share, 2018-2029
Figure 44. By Region, Global Targeted Drugs for Colorectal Cancer Sales Volume Market Share, 2018-2029
Figure 45. North America Targeted Drugs for Colorectal Cancer Revenue & Forecasts, 2018-2029, US$ Million
Figure 46. By Country, North America Targeted Drugs for Colorectal Cancer Revenue Market Share, 2022
Figure 47. Europe Targeted Drugs for Colorectal Cancer Revenue & Forecasts, 2018-2029, US$ Million
Figure 48. By Country, Europe Targeted Drugs for Colorectal Cancer Revenue Market Share, 2022
Figure 49. Asia Pacific Targeted Drugs for Colorectal Cancer Revenue & Forecasts, 2018-2029, US$ Million
Figure 50. By Country/Region, Asia Pacific Targeted Drugs for Colorectal Cancer Revenue Market Share, 2022
Figure 51. South America Targeted Drugs for Colorectal Cancer Revenue & Forecasts, 2018-2029, US$ Million
Figure 52. By Country, South America Targeted Drugs for Colorectal Cancer Revenue Market Share, 2022
Figure 53. Middle East & Africa Targeted Drugs for Colorectal Cancer Revenue & Forecasts, 2018-2029, US$ Million
Figure 54. U.S. Targeted Drugs for Colorectal Cancer Sales Volume, 2018-2029, (K Units)
Figure 55. By Company, U.S. Targeted Drugs for Colorectal Cancer Market Share, 2022
Figure 56. By Type, U.S. Targeted Drugs for Colorectal Cancer Sales Volume Market Share, 2022 VS 2029
Figure 57. By Application, U.S. Targeted Drugs for Colorectal Cancer Sales Volume Market Share, 2022 VS 2029
Figure 58. Europe Targeted Drugs for Colorectal Cancer Sales Volume, 2018-2029, (K Units)
Figure 59. By Company, Europe Targeted Drugs for Colorectal Cancer Market Share, 2022
Figure 60. By Type, Europe Targeted Drugs for Colorectal Cancer Sales Volume Market Share, 2022 VS 2029
Figure 61. By Application, Europe Targeted Drugs for Colorectal Cancer Sales Volume Market Share, 2022 VS 2029
Figure 62. China Targeted Drugs for Colorectal Cancer Sales Volume, 2018-2029, (K Units)
Figure 63. By Company, China Targeted Drugs for Colorectal Cancer Market Share, 2022
Figure 64. By Type, China Targeted Drugs for Colorectal Cancer Sales Volume Market Share, 2022 VS 2029
Figure 65. By Application, China Targeted Drugs for Colorectal Cancer Sales Volume Market Share, 2022 VS 2029
Figure 66. Japan Targeted Drugs for Colorectal Cancer Sales Volume, 2018-2029, (K Units)
Figure 67. By Company, Japan Targeted Drugs for Colorectal Cancer Market Share, 2022
Figure 68. By Type, Japan Targeted Drugs for Colorectal Cancer Sales Volume Market Share, 2022 VS 2029
Figure 69. By Application, Japan Targeted Drugs for Colorectal Cancer Sales Volume Market Share, 2022 VS 2029
Figure 70. South Korea Targeted Drugs for Colorectal Cancer Sales Volume, 2018-2029, (K Units)
Figure 71. By Company, South Korea Targeted Drugs for Colorectal Cancer Market Share, 2022
Figure 72. By Type, South Korea Targeted Drugs for Colorectal Cancer Sales Volume Market Share, 2022 VS 2029
Figure 73. By Application, South Korea Targeted Drugs for Colorectal Cancer Sales Volume Market Share, 2022 VS 2029
Figure 74. Southeast Asia Targeted Drugs for Colorectal Cancer Sales Volume, 2018-2029, (K Units)
Figure 75. By Company,
Research Methodology:
Targeted Drugs for Colorectal Cancer Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|